Bristol-Myers Squibb Co (NYSE:BMY)
| 78.89 Delayed Data As of Jun 24 |  +1.20 / +1.54%Today’s Change | 53.22 Today|||52-Week Range 79.00 | +26.53% Year-to-Date |
BMY Regular Dividend: BMY will begin trading ex-dividend on 06/30/22 with a $0.54 dividend payable to shareholders of record as of 07/01/22.
Latest BMY News | Press Releases
Today’s Trading
| Previous close | 77.69 |
| Today’s open | 78.54 |
| Day’s range | 78.13 - 79.00 |
| Volume | 12,372,297 |
| Average volume (3 months) | 15,279,822 |
| Market cap | $168.1B |
Data as of 4:10pm ET, 06/24/2022
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | +0.66% |
| Earnings growth (next 5 years) | +5.23% |
| Revenue growth (last year) | +9.09% |
| P/E ratio | 28.0 |
| Price/Sales | 3.02 |
| Price/Book | 4.78 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| NVSNovartis | +2.98 | +3.64% |
| NVONovo Nordisk | +3.73 | +3.44% |
| SNYSanofi | +3.00 | +5.95% |
| AZNAstraZeneca | +2.32 | +3.60% |
Data as of 4:08pm ET, 06/24/2022
Financials
| Next reporting date | July 27, 2022 |
| EPS forecast (this quarter) | $1.88 |
| Annual revenue (last year) | $46.4B |
| Annual profit (last year) | $7.0B |
| Net profit margin | 15.08% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters New York, New York |
Forecasts
